195 related articles for article (PubMed ID: 31193787)
1. Histologically benign metastasizing tenosynovial giant cell tumor mimicking metastatic malignancy: A case report and review of literature.
Chen EL; de Castro CM; Hendzel KD; Iwaz S; Kim MA; Valeshabad AK; Shokouh-Amiri M; Xie KL
Radiol Case Rep; 2019 Aug; 14(8):934-940. PubMed ID: 31193787
[TBL] [Abstract][Full Text] [Related]
2. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
[TBL] [Abstract][Full Text] [Related]
3. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis.
Abdul-Karim FW; el-Naggar AK; Joyce MJ; Makley JT; Carter JR
Hum Pathol; 1992 Jul; 23(7):729-35. PubMed ID: 1319390
[TBL] [Abstract][Full Text] [Related]
4. Multiple metastases from histologically benign intraarticular diffuse-type tenosynovial giant cell tumor: a case report.
Asano N; Yoshida A; Kobayashi E; Yamaguchi T; Kawai A
Hum Pathol; 2014 Nov; 45(11):2355-8. PubMed ID: 25130396
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ
BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158
[TBL] [Abstract][Full Text] [Related]
6. Metastasizing tenosynovial giant cell tumour, diffuse type/pigmented villonodular synovitis.
Righi A; Gambarotti M; Sbaraglia M; Frisoni T; Donati D; Vanel D; Dei Tos AP
Clin Sarcoma Res; 2015; 5():15. PubMed ID: 26052431
[TBL] [Abstract][Full Text] [Related]
7. Burden of Illness Associated with Tenosynovial Giant Cell Tumors.
Burton TM; Ye X; Parker ED; Bancroft T; Healey J
Clin Ther; 2018 Apr; 40(4):593-602.e1. PubMed ID: 29580718
[TBL] [Abstract][Full Text] [Related]
8. MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response assessment.
Spierenburg G; Suevos Ballesteros C; Stoel BC; Navas Cañete A; Gelderblom H; van de Sande MAJ; van Langevelde K
Insights Imaging; 2023 Feb; 14(1):22. PubMed ID: 36725759
[TBL] [Abstract][Full Text] [Related]
9. Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease.
Somerhausen NS; Fletcher CD
Am J Surg Pathol; 2000 Apr; 24(4):479-92. PubMed ID: 10757395
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W
Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900
[TBL] [Abstract][Full Text] [Related]
11. The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.
Mastboom MJ; Planje R; van de Sande MA
Interact J Med Res; 2018 Feb; 7(1):e4. PubMed ID: 29475829
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
Cassier PA; Gelderblom H; Stacchiotti S; Thomas D; Maki RG; Kroep JR; van der Graaf WT; Italiano A; Seddon B; Dômont J; Bompas E; Wagner AJ; Blay JY
Cancer; 2012 Mar; 118(6):1649-55. PubMed ID: 21823110
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology diagnosis of metastatic malignant diffuse type tenosynovial giant cell tumor.
Ramteke P; Iyer VK; Madan K; Gamangatti S; Mridha AR
J Cytol; 2017; 34(3):174-176. PubMed ID: 28701836
[TBL] [Abstract][Full Text] [Related]
14. Image-guided, intensity-modulated radiotherapy for the treatment of diffuse-type tenosynovial giant cell tumor of the knee: Case report and review of the literature.
Xiang X; Jiang W; Qiu C; Xiao N; Liang J
Medicine (Baltimore); 2021 Jul; 100(28):e26659. PubMed ID: 34260572
[TBL] [Abstract][Full Text] [Related]
15. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
Ravi V; Wang WL; Lewis VO
Curr Opin Oncol; 2011 Jul; 23(4):361-6. PubMed ID: 21577109
[TBL] [Abstract][Full Text] [Related]
16. Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee with Concurrent Polymicrobial Infection (
Marshall JH; Skedros JG; Campana CF; Seibert AM
Case Rep Infect Dis; 2021; 2021():5523212. PubMed ID: 34557317
[TBL] [Abstract][Full Text] [Related]
17. Bone Involvement Mimicking an Aggressive Bone Lesion in a Diffuse-type Tenosynovial Giant Cell Tumor in the Thoracic Vertebral Lamina: A Case Report.
Sakamoto A; Matsuyama A; Hisaoka M; Matsuda S
J Orthop Case Rep; 2018; 8(3):14-17. PubMed ID: 30584508
[TBL] [Abstract][Full Text] [Related]
18. Giant Cell Tumor in Tarsal Midfoot Bones: A Case Report.
Abed Alharbi W; Mohammed Alshareef H; Hennawi YB; Munshi AA; Khalid Alzahrani A
Cureus; 2024 Mar; 16(3):e56215. PubMed ID: 38623116
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
[TBL] [Abstract][Full Text] [Related]
20. Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases.
Mastboom MJL; Verspoor FGM; Gelderblom H; van de Sande MAJ
Case Rep Orthop; 2017; 2017():7402570. PubMed ID: 28744388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
